ArticleJournal of hematology & oncology2025

Directly reprogrammed NK cells driven by BCL11B depletion enhance targeted immunotherapy against pancreatic ductal adenocarcinoma.

Han-Seop Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.